Article
Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy.
Brain : a journal of neurology - 3 Jun 2024
Abela Lucia, Gianfrancesco Lorita, Tagliatti Erica, Rossignoli Giada, Barwick Katy, Zourray Clara, Reid Kimberley M, Budinger Dimitri, Ng Joanne, Counsell John, Simpson Arlo, Pearson Toni S, Edvardson Simon, Elpeleg Orly, Brodsky Frances M, Lignani Gabriele, Barral Serena, Kurian Manju A
Abstract excerpt
DNAJC6 encodes auxilin, a co-chaperone protein involved in clathrin-mediated endocytosis (CME) at the presynaptic terminal. Biallelic mutations in DNAJC6 cause a complex, early-onset neurodegenerative disorder characterized by rapidly progressive parkinsonism-dystonia in childhood. The disease is commonly associated with additional neurodevelopmental, neurological and neuropsychiatric features. Currently, there...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
